150 related articles for article (PubMed ID: 25695542)
1. The expression of tumor-derived and stromal-derived matrix metalloproteinase 2 predicted prognosis of ovarian cancer.
Fu Z; Xu S; Xu Y; Ma J; Li J; Xu P
Int J Gynecol Cancer; 2015 Mar; 25(3):356-62. PubMed ID: 25695542
[TBL] [Abstract][Full Text] [Related]
2. Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer.
Vos MC; van der Wurff AA; Bulten J; Kruitwagen R; Feijen H; van Kuppevelt TH; Hendriks T; Massuger LF
Diagn Pathol; 2016 Apr; 11():34. PubMed ID: 27038607
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.
Torng PL; Mao TL; Chan WY; Huang SC; Lin CT
Gynecol Oncol; 2004 Feb; 92(2):559-67. PubMed ID: 14766248
[TBL] [Abstract][Full Text] [Related]
4. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
[TBL] [Abstract][Full Text] [Related]
5. Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.
Liu C
Clin Exp Med; 2016 Aug; 16(3):375-82. PubMed ID: 26123901
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis.
Li LN; Zhou X; Gu Y; Yan J
Asian Pac J Cancer Prev; 2013; 14(7):4107-13. PubMed ID: 23991961
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis.
Jia H; Zhang Q; Liu F; Zhou D
Arch Gynecol Obstet; 2017 Mar; 295(3):689-696. PubMed ID: 27995372
[TBL] [Abstract][Full Text] [Related]
8. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
[TBL] [Abstract][Full Text] [Related]
9. The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.
Chen Y; Wang X; Chen G; Dong C; Zhang D
PLoS One; 2015; 10(3):e0121404. PubMed ID: 25816052
[TBL] [Abstract][Full Text] [Related]
10. Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer.
Périgny M; Bairati I; Harvey I; Beauchemin M; Harel F; Plante M; Têtu B
Am J Clin Pathol; 2008 Feb; 129(2):226-31. PubMed ID: 18208802
[TBL] [Abstract][Full Text] [Related]
11. The correlation between immunohistochemical expression of MMP-2 and the prognosis of epithelial ovarian cancer.
Ekinci T; Ozbay PO; Yiğit S; Yavuzcan A; Uysal S; Soylu F
Ginekol Pol; 2014 Feb; 85(2):121-30. PubMed ID: 24745158
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.
Song J; Su H; Zhou YY; Guo LL
Asian Pac J Cancer Prev; 2013; 14(3):1615-21. PubMed ID: 23679245
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer.
Sillanpää S; Anttila M; Suhonen K; Hämäläinen K; Turpeenniemi-Hujanen T; Puistola U; Tammi M; Sironen R; Saarikoski S; Kosma VM
Tumour Biol; 2007; 28(5):280-9. PubMed ID: 17962725
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of matrix metalloproteinase-9 (gelatinase-B) expression in epithelial ovarian tumors.
Ozalp S; Tanir HM; Yalcin OT; Kabukcuoglu S; Oner U; Uray M
Eur J Gynaecol Oncol; 2003; 24(5):417-20. PubMed ID: 14584660
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis.
Desmeules P; Trudel D; Turcotte S; Sirois J; Plante M; Grégoire J; Renaud MC; Orain M; Têtu B; Bairati I
Hum Pathol; 2015 May; 46(5):739-45. PubMed ID: 25771900
[TBL] [Abstract][Full Text] [Related]
18. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
[TBL] [Abstract][Full Text] [Related]
20. Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosis.
Trudel D; Desmeules P; Turcotte S; Plante M; Grégoire J; Renaud MC; Orain M; Bairati I; Têtu B
Mod Pathol; 2014 Oct; 27(10):1394-404. PubMed ID: 24603589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
